- Home
- CGEN vs FCAP Comparison
CGEN vs FCAP Comparison
Compare CGEN & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- FCAP
- Stock Information
- Founded
- CGEN 1993
- FCAP 1891
- Country
- CGEN Israel
- FCAP United States
- Employees
- CGEN N/A
- FCAP N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- FCAP Savings Institutions
- Sector
- CGEN Health Care
- FCAP Finance
- Exchange
- CGEN Nasdaq
- FCAP Nasdaq
- Market Cap
- CGEN 149.6M
- FCAP 124.2M
- IPO Year
- CGEN 2000
- FCAP 1999
- Fundamental
- Price
- CGEN $1.56
- FCAP $38.14
- Analyst Decision
- CGEN Strong Buy
- FCAP
- Analyst Count
- CGEN 1
- FCAP 0
- Target Price
- CGEN $4.00
- FCAP N/A
- AVG Volume (30 Days)
- CGEN 299.7K
- FCAP 4.7K
- Earning Date
- CGEN 03-04-2025
- FCAP 04-25-2025
- Dividend Yield
- CGEN N/A
- FCAP 3.04%
- EPS Growth
- CGEN N/A
- FCAP N/A
- EPS
- CGEN N/A
- FCAP 3.57
- Revenue
- CGEN $27,864,000.00
- FCAP $41,997,000.00
- Revenue This Year
- CGEN $22.94
- FCAP N/A
- Revenue Next Year
- CGEN $15.88
- FCAP N/A
- P/E Ratio
- CGEN N/A
- FCAP $10.67
- Revenue Growth
- CGEN N/A
- FCAP 2.23
- 52 Week Low
- CGEN $1.35
- FCAP $26.73
- 52 Week High
- CGEN $2.66
- FCAP $39.40
- Technical
- Relative Strength Index (RSI)
- CGEN 38.91
- FCAP 65.64
- Support Level
- CGEN $1.54
- FCAP $38.00
- Resistance Level
- CGEN $1.64
- FCAP $38.19
- Average True Range (ATR)
- CGEN 0.08
- FCAP 0.76
- MACD
- CGEN 0.01
- FCAP -0.17
- Stochastic Oscillator
- CGEN 26.92
- FCAP 53.03
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.